findmyKOL

Nicole Ng, MD, PHARMD

Basic profile

NewYork–Presbyterian Hospital

ORCIDNPI
RegionNew York, NY · NortheastSpecialtyPulmonary DiseaseFocusRespiratory
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2026Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Nicole Ng is a Respiratory pharmacist affiliated with NewYork–Presbyterian Hospital. OpenAlex indexes 81 publications with 765 citations (h-index 17).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
81publications

Distinct works indexed by OpenAlex, matched via ORCID.

765citations

Total citations across indexed works.

17h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
6companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

1 Gustave L Levy Pl
New York, NY 100296504

Telephone

212-241-5656

Provider last certified this registry record 13 May 2022.

View the NPPES registry record

Industry payments

6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Respiratory

    50.5%
    Corticosteroid22.2%
    Trelegy Ellipta49%Breo Ellipta21%Fluticasone Propionate19%Symbicort11%
    Part D<11 patients
    beta2-Adrenergic Agonist18.9%
    Albuterol Sulfate Hfa91%Ventolin Hfa9%
    Part D<11 patients

    + 2 more classes in this area

  • Metabolism & gastrointestinal

    24.7%
    Corticosteroid14.5%
    Prednisone100%
    Part D25 patients
    H2 blocker5.3%
    Famotidine100%
    Part D11 patients

    + 1 more class in this area

  • Cancer & immunology

    15%
    Kinase inhibitor12.8%
    Ofev100%
    Part D17 patients
    Pyridone2.2%
    Pirfenidone100%
    Part D<11 patients
Where care is delivered (Part B)62.5% facility · 37.5% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”